SAN DIEGO – First quarter revenue for ResMed Inc hit $383.6 million for the quarter ended March 31, 2013. The total marks a 10% increase over the same period last year.
Net income was $84.9 million, an increase of 31% compared to the quarter ended March 31, 2012. Diluted earnings per share were $0.58, an increase of 32%.
For the nine months ended March 31, 2013, revenue was $1.1 billion, an increase of 10% over the nine months ended March 31, 2012 (a 12% increase on a constant currency basis).
“In the third quarter of fiscal 2013, we showed strong year-over-year growth on both top and bottom lines,” said Michael “Mick” Farrell, CEO. “Revenue in the Americas increased by 13%, to $215.2 million over the prior year’s quarter. Revenue outside the Americas was $168.4 million, an increase of 6% (also a 6% increase on a constant currency basis) over the prior year’s quarter.
“We are confident we have the right product pipeline for the future,” added Farrell. “We will be launching an important and exciting new mask this quarter, and expect to launch an additional mask later this calendar year.”